Debbie Drane

2.2k total citations
32 papers, 1.7k citations indexed

About

Debbie Drane is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Debbie Drane has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Debbie Drane's work include Immunotherapy and Immune Responses (21 papers), Immune Response and Inflammation (10 papers) and T-cell and B-cell Immunology (6 papers). Debbie Drane is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Response and Inflammation (10 papers) and T-cell and B-cell Immunology (6 papers). Debbie Drane collaborates with scholars based in Australia, United Kingdom and France. Debbie Drane's co-authors include Martin J. Pearse, Eugene Maraskovsky, John C. Cox, Jeff Boyle, Sandra Koernig, Adriana Baz Morelli, Kathryn Jones, Eric J. Gowans, Anabel Silva and Max Schnurr and has published in prestigious journals such as Blood, The Journal of Immunology and Advanced Drug Delivery Reviews.

In The Last Decade

Debbie Drane

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debbie Drane Australia 26 1.1k 646 473 256 166 32 1.7k
Rinaldo Zurbriggen Switzerland 28 874 0.8× 788 1.2× 664 1.4× 422 1.6× 58 0.3× 58 2.0k
Weiguang Zeng Australia 31 1.6k 1.5× 1.1k 1.7× 1.0k 2.2× 461 1.8× 137 0.8× 89 3.0k
Risini D. Weeratna Canada 29 2.6k 2.4× 1.1k 1.6× 746 1.6× 408 1.6× 94 0.6× 58 3.6k
Isabelle Dimier‐Poisson France 27 537 0.5× 606 0.9× 716 1.5× 217 0.8× 57 0.3× 77 1.9k
Simona Tavarini Italy 22 1.2k 1.1× 398 0.6× 507 1.1× 316 1.2× 106 0.6× 38 1.8k
Evelina Angov United States 31 836 0.8× 1.0k 1.6× 282 0.6× 236 0.9× 55 0.3× 67 2.8k
Ashley J. Birkett United States 22 887 0.8× 606 0.9× 1.3k 2.8× 443 1.7× 263 1.6× 36 2.3k
Reinhard Glück Switzerland 32 1.1k 1.0× 926 1.4× 1.3k 2.8× 666 2.6× 305 1.8× 81 2.8k
Anders Sjölander Sweden 25 691 0.6× 543 0.8× 372 0.8× 185 0.7× 27 0.2× 50 1.6k
Jacqueline Conover United States 14 1.7k 1.6× 770 1.2× 412 0.9× 260 1.0× 53 0.3× 21 2.4k

Countries citing papers authored by Debbie Drane

Since Specialization
Citations

This map shows the geographic impact of Debbie Drane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Drane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Drane more than expected).

Fields of papers citing papers by Debbie Drane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Drane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Drane. The network helps show where Debbie Drane may publish in the future.

Co-authorship network of co-authors of Debbie Drane

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Drane. A scholar is included among the top collaborators of Debbie Drane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Drane. Debbie Drane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mount, Adele M., Sandra Koernig, Anabel Silva, et al.. (2013). Combination of adjuvants: the future of vaccine design. Expert Review of Vaccines. 12(7). 733–746. 56 indexed citations
2.
Zaitseva, Marina, Ksenia Blinova, Joel Beren, et al.. (2012). Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo. Vaccine. 30(32). 4859–4865. 48 indexed citations
3.
Drane, Debbie, Eugene Maraskovsky, Megan Barnden, et al.. (2009). Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers. Human Vaccines. 5(3). 151–157. 94 indexed citations
4.
Drane, Debbie, Charmaine Gittleson, Jeff Boyle, & Eugene Maraskovsky. (2007). ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines. Expert Review of Vaccines. 6(5). 761–772. 94 indexed citations
5.
Boyle, Jeff, Donna J. Eastman, Sarina Camuglia, et al.. (2006). The utility of ISCOMATRIX™ adjuvant for dose reduction of antigen for vaccines requiring antibody responses. Vaccine. 25(14). 2541–2544. 37 indexed citations
6.
Stewart, Trina J., Debbie Drane, John C. Cox, et al.. (2004). ISCOMATRIX™ adjuvant: an adjuvant suitable for use in anticancer vaccines. Vaccine. 22(27-28). 3738–3743. 31 indexed citations
7.
Pearse, Martin J. & Debbie Drane. (2004). ISCOMATRIX� adjuvant for antigen delivery. Advanced Drug Delivery Reviews. 57(3). 465–474. 137 indexed citations
8.
Pearse, Martin J. & Debbie Drane. (2004). ISCOMATRIXTM adjuvant: a potent inducer of humoral and cellular immune responses. Vaccine. 22(19). 2391–2395. 42 indexed citations
9.
Le, Thuy T., Debbie Drane, Martin J. Pearse, et al.. (2003). ISCOM® based vaccines for cancer immunotherapy. Vaccine. 22(8). 963–974. 31 indexed citations
10.
Coulter, A.R., Roslyn Davis, Debbie Drane, et al.. (2003). Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine. Vaccine. 21(9-10). 946–949. 92 indexed citations
11.
Polakos, Noelle K., Debbie Drane, John C. Cox, et al.. (2001). Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine. The Journal of Immunology. 166(5). 3589–3598. 75 indexed citations
12.
Sjölander, Sigrid, et al.. (2001). Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine. 19(28-29). 4072–4080. 48 indexed citations
13.
Le, Thuy T., Debbie Drane, John C. Cox, et al.. (2001). Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. Vaccine. 19(32). 4669–4675. 41 indexed citations
14.
Sjölander, Anders, Debbie Drane, Eugene Maraskovsky, et al.. (2001). Immune responses to ISCOM® formulations in animal and primate models. Vaccine. 19(17-19). 2661–2665. 87 indexed citations
15.
Windon, R.G., Paul Chaplin, Peter McWaters, et al.. (2001). Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX®. Vaccine. 20(3-4). 490–497. 40 indexed citations
16.
17.
Hamilton, Ross, Debbie Drane, & H.V. Smith. (1995). Shedding of “virus-like” particles in canine faeces. Veterinary Microbiology. 46(1-3). 307–313. 1 indexed citations
18.
Hamilton, Ross, et al.. (1994). Negative staining can cause clumping of Bordetella pertussis fimbriae. Micron. 25(6). 613–615. 2 indexed citations
19.
Drane, Debbie, Ross Hamilton, & John C. Cox. (1994). Evaluation of a novel diagnostic test for canine parvovirus. Veterinary Microbiology. 41(3). 293–302. 15 indexed citations
20.
Cox, John C., et al.. (1992). A novel format for a rapid sandwich EIA and its application to the identification of snake venoms. Journal of Immunological Methods. 146(2). 213–218. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026